Comprehensive panel boosts GIST diagnosis sensitivity: Rondell Graham, M.B.B.S.
Rondell Graham, M.B.B.S., describes Mayo Clinic Laboratories' new assay for gastrointestinal stromal tumors, or GIST. The panel covers multiple mutations, to better inform diagnosis and treatment options.
Audio is streamed directly from the publisher (media.transistor.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
(00:31)
Can you please provide us a little bit of background about yourself?
(01:29)
Can you give us an overview of this assay?
(02:44)
Can you talk about what genes have been added, and why?
(04:16)
Can you talk about patients who should have this testing?
(06:20)
Are there any last comments that you would like to make about the new gastrointestinal tumor panel?